Mechanistic understanding of the role of ATRX in senescence provides new insight for combinatorial therapies with CDK4 inhibitors Journal Article


Authors: Kovatcheva, M.; Klein, M. E.; Tap, W. D.; Koff, A.
Article Title: Mechanistic understanding of the role of ATRX in senescence provides new insight for combinatorial therapies with CDK4 inhibitors
Abstract: Senescence is an irreversible form of growth arrest and is generally considered a favorable outcome of cancer therapies, yet little is known about the molecular events that distinguish this state from readily reversible growth arrest (i.e. quiescence). Recently, we discovered that during therapy induced senescence the chromatin remodeling protein alpha-thalassemia, mental retardation, X-linked (ATRX) represses Harvey rat sarcoma viral oncogene homolog (HRAS), and repression of HRAS is necessary to establish senescence, suggesting how new clinical combinations might be used to achieve durable senescence.
Keywords: expression; cellular senescence; atrx; heterochromatin formation; foci; cdk4 inhibitors; geroconversion; therapy induced senescence
Journal Title: Molecular & Cellular Oncology
Volume: 5
Issue: 1
ISSN: 2372-3556
Publisher: Taylor & Francis Group  
Date Published: 2018-01-01
Start Page: e1384882
Language: English
ACCESSION: WOS:000428756800008
DOI: 10.1080/23723556.2017.1384882
PROVIDER: wos
PMCID: PMC5791849
PUBMED: 29404388
Notes: Editorial Material -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew C Koff
    110 Koff
  2. William Douglas Tap
    374 Tap
  3. Mary Elizabeth Klein
    10 Klein